80 related articles for article (PubMed ID: 21391896)
1. Detection of advanced oxidation protein products in patients with chronic kidney disease by a novel monoclonal antibody.
Liu B; Hou X; Zhou Q; Tian J; Zhu P; Xu J; Hou F; Fu N
Free Radic Res; 2011 Jun; 45(6):662-71. PubMed ID: 21391896
[TBL] [Abstract][Full Text] [Related]
2. Overestimation of advanced oxidation protein products in uremic plasma due to presence of triglycerides and other endogenous factors.
Valli A; Suliman ME; Meert N; Vanholder R; Lindholm B; Stenvinkel P; Watanabe M; Barany P; Alvestrand A; Anderstam B
Clin Chim Acta; 2007 Apr; 379(1-2):87-94. PubMed ID: 17292872
[TBL] [Abstract][Full Text] [Related]
3. Advanced oxidation protein products accelerate renal fibrosis in a remnant kidney model.
Li HY; Hou FF; Zhang X; Chen PY; Liu SX; Feng JX; Liu ZQ; Shan YX; Wang GB; Zhou ZM; Tian JW; Xie D
J Am Soc Nephrol; 2007 Feb; 18(2):528-38. PubMed ID: 17202414
[TBL] [Abstract][Full Text] [Related]
4. Selective oxidation of DNA topoisomerase 1 induces systemic sclerosis in the mouse.
Servettaz A; Goulvestre C; Kavian N; Nicco C; Guilpain P; Chéreau C; Vuiblet V; Guillevin L; Mouthon L; Weill B; Batteux F
J Immunol; 2009 May; 182(9):5855-64. PubMed ID: 19380834
[TBL] [Abstract][Full Text] [Related]
5. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
[TBL] [Abstract][Full Text] [Related]
6. A new oxidative stress marker in patients with nasal polyposis: advanced oxidation protein products (AOPP).
Veyseller B; Aksoy E; Ertaş B; Keskin M; Ozturan O; Yildirim YS; Bayraktar EG; Oztürk H
B-ENT; 2010; 6(2):105-9. PubMed ID: 20681362
[TBL] [Abstract][Full Text] [Related]
7. Human blood plasma advanced oxidation protein products (AOPP) correlates with fibrinogen levels.
Selmeci L; Székely M; Soós P; Seres L; Klinga N; Geiger A; Acsády G
Free Radic Res; 2006 Sep; 40(9):952-8. PubMed ID: 17015275
[TBL] [Abstract][Full Text] [Related]
8. Advanced Oxidation Protein Products-Modified Albumin Induces Differentiation of RAW264.7 Macrophages into Dendritic-Like Cells Which Is Modulated by Cell Surface Thiols.
Garibaldi S; Barisione C; Marengo B; Ameri P; Brunelli C; Balbi M; Ghigliotti G
Toxins (Basel); 2017 Jan; 9(1):. PubMed ID: 28075404
[TBL] [Abstract][Full Text] [Related]
9. Principal component analysis of some oxidative stress parameters and their relationships in hemodialytic and transplanted patients.
Antolini F; Valente F; Ricciardi D; Baroni M; Fagugli RM
Clin Chim Acta; 2005 Aug; 358(1-2):87-94. PubMed ID: 15885684
[TBL] [Abstract][Full Text] [Related]
10. Advanced oxidation protein products (AOPP): novel uremic toxins, or components of the non-enzymatic antioxidant system of the plasma proteome?
Selmeci L
Free Radic Res; 2011 Oct; 45(10):1115-23. PubMed ID: 21740311
[TBL] [Abstract][Full Text] [Related]
11. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure.
Witko-Sarsat V; Friedlander M; Nguyen Khoa T; Capeillère-Blandin C; Nguyen AT; Canteloup S; Dayer JM; Jungers P; Drüeke T; Descamps-Latscha B
J Immunol; 1998 Sep; 161(5):2524-32. PubMed ID: 9725252
[TBL] [Abstract][Full Text] [Related]
12. The oxidation induced by antimyeloperoxidase antibodies triggers fibrosis in microscopic polyangiitis.
Guilpain P; Chéreau C; Goulvestre C; Servettaz A; Montani D; Tamas N; Pagnoux C; Hachulla E; Weill B; Guillevin L; Mouthon L; Batteux F
Eur Respir J; 2011 Jun; 37(6):1503-13. PubMed ID: 21071471
[TBL] [Abstract][Full Text] [Related]
13. Does renal function influence plasma levels of advanced glycation and oxidation protein products in patients with chronic rheumatic diseases complicated by secondary amyloidosis?
Rysavá R; Kalousová M; Zima T; Dostál C; Merta M; Tesar V
Kidney Blood Press Res; 2007; 30(1):1-7. PubMed ID: 17191033
[TBL] [Abstract][Full Text] [Related]
14. Modification of the oxidative stress biomarker AOPP assay: application in uremic samples.
Anderstam B; Ann-Christin BH; Valli A; Stenvinkel P; Lindholm B; Suliman ME
Clin Chim Acta; 2008 Jul; 393(2):114-8. PubMed ID: 18423381
[TBL] [Abstract][Full Text] [Related]
15. Improved detection of advanced oxidation protein products in plasma.
Hanasand M; Omdal R; Norheim KB; Gøransson LG; Brede C; Jonsson G
Clin Chim Acta; 2012 May; 413(9-10):901-6. PubMed ID: 22336637
[TBL] [Abstract][Full Text] [Related]
16. [Levels of advanced oxidation protein products (AOPP) in the first trimester of pregnancy].
Fialová L; Kalousová M; Soukupová J; Malbohan I; Krofta L; Mikulíková L; Horejsová H; Stípek S; Zima T
Sb Lek; 2003; 104(1):95-102. PubMed ID: 14577140
[TBL] [Abstract][Full Text] [Related]
17. Respective role of uraemic toxins and myeloperoxidase in the uraemic state.
Capeillère-Blandin C; Gausson V; Nguyen AT; Descamps-Latscha B; Drüeke T; Witko-Sarsat V
Nephrol Dial Transplant; 2006 Jun; 21(6):1555-63. PubMed ID: 16476719
[TBL] [Abstract][Full Text] [Related]
18. Advanced oxidation protein products: a novel marker of oxidative stress in ulcerative colitis.
Baskol M; Baskol G; Koçer D; Ozbakir O; Yucesoy M
J Clin Gastroenterol; 2008 Jul; 42(6):687-91. PubMed ID: 18574392
[TBL] [Abstract][Full Text] [Related]
19. Increased level of advanced oxidation products (AOPP) as a marker of oxidative stress in patients with acute coronary syndrome.
Skvarilová M; Bulava A; Stejskal D; Adamovská S; Bartek J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Jun; 149(1):83-7. PubMed ID: 16170393
[TBL] [Abstract][Full Text] [Related]
20. The plasma concentration of advanced oxidation protein products and arterial stiffness in apparently healthy adults.
Wykretowicz A; Adamska K; Krauze T; Guzik P; Szczepanik A; Rutkowska A; Wysoki H
Free Radic Res; 2007 Jun; 41(6):645-9. PubMed ID: 17516236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
